Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access
Pancreas and spleen removed to minimize risk of pancreatic cancer
Focus is exocrine pancreatic stem cell development
Study shows challenges of implementing an impactful regimen
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Add prophylaxis for patients receiving systemic therapy
Preoperative chemo approach in pancreatic cancer
Know Your Tumor initiative matches treatments with patients
New recommendations for second-line therapy
Does tumor location matter?
Researchers consider alternatives for high-risk patients